CDMO

PCI Pharma Services Invests $365 Million in US, EU Facilities for Advanced Drug Delivery: A Strategic Expansion

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies, announced...